• No results found

[PDF] Top 20 <p>Novel cancer therapy targeting microbiome</p>

Has 10000 "<p>Novel cancer therapy targeting microbiome</p>" found on our website. Below are the top 20 most common "<p>Novel cancer therapy targeting microbiome</p>".

&lt;p&gt;Novel cancer therapy targeting microbiome&lt;/p&gt;

<p>Novel cancer therapy targeting microbiome</p>

... colorectal cancer include the following: the alpha-bug hypothesis, driver-passenger hypothesis, bio fi lm hypothesis and bystander effect ...colorectal cancer carcino- genesis, which involves lack of ... See full document

6

&lt;p&gt;The Role of DLLs in Cancer: A Novel Therapeutic Target&lt;/p&gt;

<p>The Role of DLLs in Cancer: A Novel Therapeutic Target</p>

... To promote the tumor-suppressive functions of DLLs and to avoid oncogenicity, numerous DLL-targeting stra- tegies have been proposed. These include (1) DLL mimics that can activate or inactivate Notch signaling, ... See full document

21

Targeting FBPase is an emerging novel approach for cancer therapy

Targeting FBPase is an emerging novel approach for cancer therapy

... conditions, cancer cells have to reprogram their metabolic and epi- genetic phenotypes through the activation of oncogenes and inactivation of tumour-suppressor genes, altering the pattern of epigenetic ... See full document

16

&lt;p&gt;MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers&lt;/p&gt;

<p>MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers</p>

... individuals over age 60 can also be observed. In young patients, it usually stem from the metaphyses of long bones, such as the distal femur, proximal tibia, and prox- imal humerus. 71 Despite signi fi cant advancements ... See full document

13

&lt;p&gt;Subcellular Performance of Nanoparticles in Cancer Therapy&lt;/p&gt;

<p>Subcellular Performance of Nanoparticles in Cancer Therapy</p>

... for cancer therapy are predominantly administered through the intravenous route, which could circulate systemically throughout the blood circulation due to their tiny sizes providing extended circulation in ... See full document

30

&lt;p&gt;Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p&lt;/p&gt;

<p>Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p</p>

... Breast cancer (BC) is one of the most frequently occurring malignancies, affecting millions of people ...American Cancer Society, there will be 271,270 new cases of and 42,260 deaths from BC in the United ... See full document

13

&lt;p&gt;Exosomes as Actively Targeted Nanocarriers for Cancer Therapy&lt;/p&gt;

<p>Exosomes as Actively Targeted Nanocarriers for Cancer Therapy</p>

... widely used as a biologically carrier of therapeutic materi- als, as its great drug loading capacity, high speci fi city and low immunogenicity are natural advantages that other nanometer materials do not have. The ... See full document

17

MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1

MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1

... lung cancer stem cells ...in cancer and the upstream control of Notch activation in lung cancer currently remain ...human cancer through the Notch signaling pathway ...lung cancer ... See full document

12

&lt;p&gt;Metastasis inhibition in breast cancer by targeting cancer cell extravasation&lt;/p&gt;

<p>Metastasis inhibition in breast cancer by targeting cancer cell extravasation</p>

... The angiogenic switch in hypoxic tumors frequently results in abnormal vasculature regarding its structure and function. 25 An irregular branching network, lack of directional fl ow and compressed walls among other ... See full document

14

&lt;p&gt;Research Progress in microRNA-Based Therapy for Gastric Cancer&lt;/p&gt;

<p>Research Progress in microRNA-Based Therapy for Gastric Cancer</p>

... all cancer treatments, it is considered to be a particularly more complex problem in the clinical treatment of ...by targeting ATP binding cassette subfamily B member 1 (ABCB1) and zinc ribbon ... See full document

19

&lt;p&gt;Comparison of Gut Microbiome in Human Colorectal Cancer in Paired Tumor and Adjacent Normal Tissues&lt;/p&gt;

<p>Comparison of Gut Microbiome in Human Colorectal Cancer in Paired Tumor and Adjacent Normal Tissues</p>

... Tumour-nodes-metastasis (TNM) staging system pro- vides crucial clinical management for therapy of patients with cancers. 8 Despite many molecular features (i.e., cyto- toxic CD8/CD45, proteins, p38) being ... See full document

12

&lt;p&gt;Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6&lt;/p&gt;

<p>Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6</p>

... Results: In this research, we discovered that LINC00565, a novel lncRNA, was highly expressed in ovarian cancer (OC). LINC00565 expression level was negatively associated with outcomes of OC patients. ... See full document

12

&lt;p&gt;Targeting stem cells in the realm of drug-resistant breast cancer&lt;/p&gt;

<p>Targeting stem cells in the realm of drug-resistant breast cancer</p>

... breast cancer (BC) has been a conundrum that ails millions of women every ...This cancer has been well studied by researchers all over the world, which has improved the patient outcome ...this cancer ... See full document

21

Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors

Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors

... treat cancer. Based on the fact that targeting of leptin could be considered as a novel strategy for breast cancer therapy, the aim of this study is the investigation of potentiality of ... See full document

7

&lt;p&gt;Natural gypenosides: targeting cancer through different molecular pathways&lt;/p&gt;

<p>Natural gypenosides: targeting cancer through different molecular pathways</p>

... WHO, cancer causes more deaths than stroke or any coronary heart ...1 Cancer cases increase because of numerous risk factors, aging, and population ...that cancer will increase in the next decades, ... See full document

11

&lt;p&gt;Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo&lt;/p&gt;

<p>Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo</p>

... larly cancer, cells lose their ability to undergo apoptosis induced death leading to uncontrolled ...ovarian cancer in the nude mice, apoptotic proteins were determined by Western blot assay (Figure ... See full document

14

&lt;p&gt;Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer&lt;/p&gt;

<p>Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer</p>

... Colorectal cancer (CRC) remains the third most prevalent cancer type and leading cause of cancer-related deaths with 1.8 million cases and 862,000 deaths worldwide during 2018. 1 The occurrence and ... See full document

13

&lt;p&gt;MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review&lt;/p&gt;

<p>MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review</p>

... by targeting their mRNA transcripts in controlling the expres- sion of the MYC ...creatic cancer cells and ...BCL2. Targeting insulin-like growth factor 1 receptor (IGF1R) has been con fi rmed as a ... See full document

12

&lt;p&gt;miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer&lt;/p&gt;

<p>miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer</p>

... We predicted potential target genes of miR-492 by bioinformatics analysis and selected GJB4 for further analysis (Figure 5A). Luciferase activity from a reporter plasmid carrying wild-type, but not mutant, GJB4 3 ʹ -UTR ... See full document

12

&lt;p&gt;Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report&lt;/p&gt;

<p>Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report</p>

... As a result, gratifying outcomes were achieved regarding a durable response and overall survival of more than 30 and 41 weeks, respectively. Although the degree of tracheal stenosis was slightly more severe than that ... See full document

6

Show all 10000 documents...